142 related articles for article (PubMed ID: 24663822)
41. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU.
Ng CS; Shaw AD; Bell CS; Samuels JA
AJR Am J Roentgenol; 2010 Aug; 195(2):414-22. PubMed ID: 20651198
[TBL] [Abstract][Full Text] [Related]
42. Contrast-induced nephropathy (CIN) of patients with renal dysfunction in CT examination.
Fukushima Y; Miyazawa H; Nakamura J; Taketomi-Takahashi A; Suto T; Tsushima Y
Jpn J Radiol; 2017 Aug; 35(8):427-431. PubMed ID: 28528465
[TBL] [Abstract][Full Text] [Related]
43. Administration of iodinated contrast: What is the risk in cancer patients?
González Cervantes JJ; Mascarós Martínez JM; Arana E
Eur J Cancer Care (Engl); 2021 Jan; 30(1):e13351. PubMed ID: 33135211
[TBL] [Abstract][Full Text] [Related]
44. Subclinical Contrast-Induced Acute Kidney Injury in Patients Undergoing Cerebral Computed Tomography.
Breglia A; Godi I; Virzì GM; Guglielmetti G; Iannucci G; De Cal M; Brocca A; Carta M; Giavarina D; Ankawi G; Passannante A; Yun X; Biolo G; Ronco C
Cardiorenal Med; 2020; 10(2):125-136. PubMed ID: 32036364
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the nephrotoxicity of iodixanol in patients with predisposing factors to contrast medium induced nephropathy referred for contrast enhanced computed tomography.
Sandstede JJ; Roth A; Machann W; Kaupert C; Hahn D
Eur J Radiol; 2007 Jul; 63(1):120-3. PubMed ID: 17317065
[TBL] [Abstract][Full Text] [Related]
46. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.
Stacul F; van der Molen AJ; Reimer P; Webb JA; Thomsen HS; Morcos SK; Almén T; Aspelin P; Bellin MF; Clement O; Heinz-Peer G;
Eur Radiol; 2011 Dec; 21(12):2527-41. PubMed ID: 21866433
[TBL] [Abstract][Full Text] [Related]
47. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.
Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; Ommen VV; Wildberger JE
Lancet; 2017 Apr; 389(10076):1312-1322. PubMed ID: 28233565
[TBL] [Abstract][Full Text] [Related]
48. A 5-item prediction rule to identify severe renal dysfunction in patients with acute stroke.
Vergouwen MD; Fang J; Casaubon LK; Kapral MK; Stamplecoski M; Robertson A; Silver FL;
AJNR Am J Neuroradiol; 2012 Sep; 33(8):1449-54. PubMed ID: 22492569
[TBL] [Abstract][Full Text] [Related]
49. The contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy after primary percutaneous coronary intervention.
Liu Y; Tan N; Zhou YL; He PC; Luo JF; Chen JY
Int Urol Nephrol; 2012 Feb; 44(1):221-9. PubMed ID: 21336957
[TBL] [Abstract][Full Text] [Related]
50. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease.
Toprak O; Cirit M; Yesil M; Bayata S; Tanrisev M; Varol U; Ersoy R; Esi E
Nephrol Dial Transplant; 2007 Mar; 22(3):819-26. PubMed ID: 17090607
[TBL] [Abstract][Full Text] [Related]
51. Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate.
McDonald JS; McDonald RJ; Carter RE; Katzberg RW; Kallmes DF; Williamson EE
Radiology; 2014 Apr; 271(1):65-73. PubMed ID: 24475854
[TBL] [Abstract][Full Text] [Related]
52. Contrast Volume to Cystatin C-Based Glomerular Filtration Ratio Predicts the Risk of Contrast-Induced Nephropathy After Cardiac Catheterization.
Zhao JB; Liu Y; Wu DX; Chen JY; Duan CY; Chen SQ; Tan N
Angiology; 2017 Mar; 68(3):207-215. PubMed ID: 27166381
[TBL] [Abstract][Full Text] [Related]
53. Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease.
Fujita D; Takahashi M; Doi K; Abe M; Tazaki J; Kiyosue A; Myojo M; Ando J; Fujita H; Noiri E; Sugaya T; Hirata Y; Komuro I
Heart Vessels; 2015 May; 30(3):296-303. PubMed ID: 24554034
[TBL] [Abstract][Full Text] [Related]
54. [Iodinated contrast agent-induced nephropathy].
Erley C
Radiologe; 2007 Sep; 47(9):761-7. PubMed ID: 17823784
[TBL] [Abstract][Full Text] [Related]
55. Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol.
Werner S; Bez C; Hinterleitner C; Horger M
PLoS One; 2020; 15(5):e0233433. PubMed ID: 32437415
[TBL] [Abstract][Full Text] [Related]
56. Is point of care renal function testing reliable screening pre-IV contrast administration?
Mathur N; Lu ZX; MacKay L; Lau T; Kuganesan A; Lau KK
Emerg Radiol; 2021 Feb; 28(1):77-82. PubMed ID: 32725604
[TBL] [Abstract][Full Text] [Related]
57. Safety of a rapid outpatient hydration protocol for patients with renal impairment requiring intravenous iodinated contrast media for computed tomography.
Wee NK; Tiong SC; Lee CH; H'ng MWC
Singapore Med J; 2021 Nov; 62(11):588-593. PubMed ID: 32460449
[TBL] [Abstract][Full Text] [Related]
58. Incidence and outcomes of contrast-induced AKI following computed tomography.
Weisbord SD; Mor MK; Resnick AL; Hartwig KC; Palevsky PM; Fine MJ
Clin J Am Soc Nephrol; 2008 Sep; 3(5):1274-81. PubMed ID: 18463172
[TBL] [Abstract][Full Text] [Related]
59. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
Bilasy ME; Oraby MA; Ismail HM; Maklady FA
J Interv Cardiol; 2012 Aug; 25(4):404-10. PubMed ID: 22612071
[TBL] [Abstract][Full Text] [Related]
60. Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT--a pooled analysis of two randomized trials.
Thomsen HS; Morcos SK
Eur Radiol; 2009 Apr; 19(4):891-7. PubMed ID: 19002467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
